Trial · NCT07914439
Inspiratory Muscle Training in Axial Spondyloarthritis
NCT07914439, Not applicable, Completed, Bursa Yuksek Ihtisas Training and Research Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Inspiratory Muscle Training in Axial Spondyloarthritis. Trials, record NCT07914439. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914439
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Inspiratory Muscle Training in Axial Spondyloarthritis
- NCT number
- NCT07914439
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 42 participants, actual
- Lead sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Conditions
- Axial Spondyloarthritis (AxSpA)
- Interventions
- Aerobic Exercise, Conventional Spinal Mobility Exercises, Inspiratory Muscle Training
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Right Diaphragmatic End-Inspiratory Thickness | Baseline (Week 0) and Week 12 | Right diaphragmatic end-inspiratory thickness was assessed using B-mode ultrasonography during deep inspiration. Three measurements were averaged. Thickness was recorded in centimeters, and change from baseline to Week 12 was evaluated. |
| Primary | Change in Left Diaphragmatic End-Inspiratory Thickness | Baseline (Week 0) and Week 12 | Left diaphragmatic end-inspiratory thickness was measured using B-mode ultrasonography during deep inspiration. Three measurements were averaged, and the change in thickness, expressed in centimeters, was evaluated from baseline to Week 12. |
| Primary | Change in Ankylosing Spondylitis Disease Activity Score with C-Reactive Protein (ASDAS-CRP) | Baseline (Week 0) and Week 12 | Disease activity was evaluated using ASDAS-CRP, a composite index incorporating patient-reported symptoms and serum C-reactive protein. Higher scores indicate greater disease activity. Change from baseline to Week 12 was assessed. |
| Primary | Change in Six-Minute Walk Test Distance (6MWT) | Baseline (Week 0) and Week 12 | Functional exercise capacity was evaluated using the six-minute walk test. The total distance walked during six minutes was recorded in meters. Change in walking distance from baseline to Week 12 was assessed. |
| Secondary | Change in Bath Ankylosing Spondylitis Functional Index (BASFI) | Baseline (Week 0) and Week 12 | Functional limitations were evaluated using the 10-item Bath Ankylosing Spondylitis Functional Index. Total scores range from 0 to 10, with higher scores indicating greater functional impairment. Change from baseline to Week 12 was assessed. |
| Secondary | Change in Fatigue Severity Scale (FSS) Score | Baseline (Week 0) and Week 12 | Fatigue was evaluated using the nine-item Fatigue Severity Scale. The mean item score ranges from 1 to 7, with higher scores indicating greater fatigue severity. Change from baseline to Week 12 was assessed. |
| Secondary | Change in Pittsburgh Sleep Quality Index (PSQI) Global Score | Baseline (Week 0) and Week 12 | Sleep quality was assessed using the Pittsburgh Sleep Quality Index, with global scores ranging from 0 to 21. Higher scores indicate poorer sleep quality. Change from baseline to Week 12 was assessed. |
| Secondary | Change in Chest Expansion | Baseline (Week 0) and Week 12 | Chest expansion was assessed using a measuring tape at the nipple line while standing. The difference between maximal inspiration and maximal expiration was measured in centimeters at baseline and Week 12. |
| Secondary | Change in Short Form-36 (SF-36) Health Survey Domain Scores | Baseline (Week 0) and Week 12 | Health-related quality of life was assessed using the eight domains of the SF-36 Health Survey. Domain scores range from 0 to 100, with higher scores indicating better health-related quality of life. Changes from baseline to Week 12 were assessed. |
| Secondary | Change in Right Diaphragmatic End-Expiratory Thickness | Baseline (Week 0) and Week 12 | Right diaphragmatic thickness was measured during deep expiration using B-mode ultrasonography. Three measurements were averaged. Thickness was recorded in centimeters at baseline and Week 12. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07914439
GET https://conductscience.org/api/trials/v1/NCT07914439/registered